Chemcon Speciality Chemicals Limited
NSE:CHEMCON.NS
231.38 (INR) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,670.921 | 3,028.847 | 2,567.493 | 2,432.271 | 2,612.6 | 3,026.83 | 1,567.91 | 876.37 | 966.86 |
| Cost of Revenue
| 2,171.922 | 1,757.438 | 1,396.568 | 1,343.93 | 1,671.36 | 2,054.29 | 871.32 | 701.94 | 649.963 |
| Gross Profit
| 498.999 | 1,271.409 | 1,170.925 | 1,088.341 | 941.24 | 972.54 | 696.59 | 174.43 | 316.897 |
| Gross Profit Ratio
| 0.187 | 0.42 | 0.456 | 0.447 | 0.36 | 0.321 | 0.444 | 0.199 | 0.328 |
| Reseach & Development Expenses
| 1.448 | 0.995 | 0 | 0 | 0 | 0 | 0 | 0 | 0.203 |
| General & Administrative Expenses
| 22.85 | 51.695 | 51.944 | 42.345 | 36.7 | 25.8 | 16.46 | 0 | 219.376 |
| Selling & Marketing Expenses
| 47.853 | 98.059 | 94.934 | 62.534 | 54.62 | 45.7 | 39.47 | 0 | 0.752 |
| SG&A
| 333.296 | 149.754 | 146.878 | 104.879 | 91.32 | 71.5 | 55.93 | 108.46 | 220.127 |
| Other Expenses
| 131.845 | 133.147 | 0.005 | 9.753 | 0.22 | 269 | 210.23 | -1.45 | 0 |
| Operating Expenses
| 333.296 | 648.156 | 410.346 | 331.36 | 281.06 | 340.5 | 266.16 | 109.91 | 242.936 |
| Operating Income
| 572.351 | 623.352 | 760.579 | 756.979 | 656.976 | 632.7 | 430.43 | 64.52 | 76.268 |
| Operating Income Ratio
| 0.214 | 0.206 | 0.296 | 0.311 | 0.251 | 0.209 | 0.275 | 0.074 | 0.079 |
| Total Other Income Expenses Net
| -309.775 | -298.821 | -273.937 | -274.937 | -10.955 | -20.01 | -24.92 | -20.22 | -26.678 |
| Income Before Tax
| 262.576 | 741.514 | 839.955 | 760.557 | 649.23 | 612.03 | 405.51 | 44.3 | 49.59 |
| Income Before Tax Ratio
| 0.098 | 0.245 | 0.327 | 0.313 | 0.248 | 0.202 | 0.259 | 0.051 | 0.051 |
| Income Tax Expense
| 70.646 | 190.414 | 212.389 | 196.575 | 160.7 | 181.62 | 141.7 | 16.06 | 17.136 |
| Net Income
| 191.93 | 551.101 | 627.566 | 563.982 | 488.525 | 430.41 | 263.81 | 28.24 | 32.454 |
| Net Income Ratio
| 0.072 | 0.182 | 0.244 | 0.232 | 0.187 | 0.142 | 0.168 | 0.032 | 0.034 |
| EPS
| 5.24 | 15.04 | 17.13 | 16.48 | 15.37 | 11.75 | 7.2 | 0.89 | 1.02 |
| EPS Diluted
| 5.24 | 15.04 | 17.13 | 16.48 | 15.37 | 11.75 | 7.2 | 0.89 | 1.02 |
| EBITDA
| 400.642 | 840.114 | 908.339 | 852.15 | 742.26 | 680.69 | 456.81 | 87.88 | 98.682 |
| EBITDA Ratio
| 0.15 | 0.277 | 0.356 | 0.355 | 0.281 | 0.221 | 0.287 | 0.1 | 0.102 |